Alphyn Biologics
Signal active
Organization
Contact Information
Overview
Alphyn Biologics is a life science company that develops proprietary drug therapy for treating skin diseases. Alphyn's initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on their proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform.
About
Industries
Life Science, Health Care, Pharmaceutical, Therapeutics
Founded
2019
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Alphyn Biologics headquartered in United States, North America, operates in the Life Science, Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Life Science and has secured $757.0M in funding across 64 round(s). With a team of 1-10 employees, Alphyn Biologics is actively contributing to advancements in Life Science. Their latest funding round, Venture Round - Alphyn Biologics, raised $1.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$11.8M
Details
1
Alphyn Biologics has raised a total of $11.8M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Early Stage Venture | 3.3M |
Investors
Alphyn Biologics is funded by 6 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Alphyn Biologics | - | FUNDING ROUND - Alphyn Biologics | 3.3M |
| Queen City Angels | - | FUNDING ROUND - Queen City Angels | 3.3M |
| Alphyn Biologics | - | FUNDING ROUND - Alphyn Biologics | 3.3M |
| Serial Stage Venture Partners | - | FUNDING ROUND - Serial Stage Venture Partners | 3.3M |
Recent Activity
There is no recent news or activity for this profile.